Given shared clinical features with AD, such as amyloid beta deposition, mislocalization of aquaporin-4 (AQP-4), cerebrovascular inflammation, and sleep disturbance11, probing underlying biomarkers for the diagnosis of iNPH has been in crying need. This evidence concerns the gene AQP4 and Alzheimer disease.